BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...

Geode Capital Management LLC grew its stake in shares of STAAR Surgical (NASDAQ:STAA – Free Report) by 2.7% during the third ...

It was revealed in a recent SEC filing that BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical (NASDAQ:STAA) made a noteworthy insider purchase on December 19,. What Happened: In a recent Form 4 ...

STAAR Surgical (NASDAQ:STAA – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday .The company traded as low as $23.55 and last traded at $23.75, with a ...

LAKE FOREST, Calif., November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for ...

Canaccord analyst William Plovanic lowered the firm’s price target on Staar Surgical (STAA) to $28 from $31 and keeps a Hold rating on the shares. Canaccord said they are bullish on the Med-Tech ...

2207 [email protected] Source: STAAR Surgical Company The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

STAAR Surgical Co. (NASDAQ:STAA), a leader in ophthalmic surgery products with a robust 79% gross profit margin, has seen its stock price touch a 52-week low, trading at $23.56. According to ...